Vertex Pharmaceuticals | LinkedIn (original) (raw)

About us

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.

Industry

Biotechnology Research

Company size

1,001-5,000 employees

Headquarters

Boston, MA

Type

Public Company

Founded

1989

Specialties

cystic fibrosis, alpha-1 antitrypsin deficiency (AATD), APOL1-mediated kidney diseases, sickle cell disease, beta thalassemia, Duchenne muscular dystrophy, and type 1 diabetes mellitus

Locations

Primary
Vertex Pharmaceuticals Inc.
50 Northern Avenue
Boston, MA 02210, US
Get directions
2 Kingdom Street
Paddington, London W2 6BD, GB
Get directions
3215 Merryfield Row
San Diego, California 92121, US
Get directions
Calle Marqués de Villamagna
Madrid, Spain 28001, ES
Get directions
601 Pacific Hwy
Sydney, NSW 2065, AU
Get directions
86-88 Jubilee Avenue
Milton Park, Abingdon, Oxfordshire OX14 4RW, GB
Get directions

Employees at Vertex Pharmaceuticals

Updates

Patients are at the center of everything we do. As we engage with the cystic fibrosis (CF) community at #NACFC2024, we’re excited to share our journey and learn from those who inspire our work. Hear Rebecca Hunt, Vice President of Patient & Community Engagement, discuss our unwavering commitment to the CF community and how they are driving our commitment to people living with the disease: https://lnkd.in/er9iyUM2
As we head to our hometown of Boston for the North American Cystic Fibrosis Conference (NACFC), we’re reflecting on the incredible progress made over the past five years in our cystic fibrosis (CF) program. We can’t wait to share this progress and connect with the CF community. Learn more about our commitment: https://lnkd.in/eYNYZhnt
News from #NACFC2024: We are presenting new data on our cystic fibrosis medicines at the 2024 North American Cystic Fibrosis Conference. Learn more: https://lnkd.in/enYuwYy7
This National Intern Week in the UK we’re thrilled to welcome our new cohort of early talent graduates and students to our London Paddington and Oxford offices. Joining us from universities across the UK, they will embed themselves within Vertex, learning the skills needed to launch a successful career in biotech. We’re excited to see what they achieve during their time here! Learn more about our early career programs across the globe: https://lnkd.in/e-Y2GPas
When it comes to serving our communities, we strive to maximize impact by empowering employees to give back and use their time, talent and resources to support causes they care about. This year, for our 16th annual Global Week of Service, Vertexians everywhere — from the U.S. to the U.K., Austria, Canada, Italy, Australia and more — spent time in our local communities for a paid day of volunteering. Vertexians: why do you give back? #VertexVolunteers
Every day we’re inspired by the cystic fibrosis (CF) researchers who work tremendously hard to do the impossible and research innovative therapies to improve the lives of those living with serious diseases. We’re committed to inspiring the next generation of #CysticFibrosis research-focused PhDs and MDs through our competitive CF award programs. Is this you or someone you know? Apply today: https://lnkd.in/ehGD4kfd
Applications for our Vertex Innovation Awards are now open! If you are interested in establishing a career in cystic fibrosis (CF) research to improve the care of patients with CF, apply now: https://lnkd.in/ehGD4kfd
We have committed over 20 years of research to help people living with pain. It’s our privilege to join the community in recognizing September as Pain Awareness Month.
This #SickleCellAwarenessMonth, we’re partnering with Scientific American to share our teams’ work in highlighting the health inequities and humanistic and economic burden of sickle cell disease in an effort to inform health care decision-making. Learn more in this piece featuring Vertexian Nanxin (Nick) Li: https://lnkd.in/eHPcJNDR

Join now to see what you are missing

Join now

Browse jobs

Stock

VRTX

September 30, 2024

NASDAQ

20 minutes delay

Open

463.16

Low

462.36

High

467.57

Data from Refinitiv

See more info on Bing